| Patient | Lorraine Hansberry |
|---|---|
| Date of birth | 1993-05-19 |
| Identifiers | MRN HR-ML034-SYN; SSN (made up) 000-34-7158 |
| Document date | 2026-04-20 |
| Author | Odette Marchetti-Fields, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Suspected pancreatic or duodenal cancer in a 32-year-old playwright with two months of epigastric pain boring through to the back, a 5 kg weight loss, black stools with iron deficiency anemia (hemoglobin 9.1 g/dL, ferritin 6 ng/mL), new diabetes (A1c 6.6%) and a cholestatic liver pattern. Upper endoscopy and pancreas-protocol CT are booked this week. Please see her within two weeks to review the results with her and plan treatment if cancer is found. [S]
Urgency: Urgent, within two weeks. [S]
Questions for the consultant:
Two months of burning, boring epigastric pain into the back, worse after meals and lying flat, with nausea, early fullness and pale loose stools; black stools on and off for three weeks; two near-fainting spells. An urgent care visit five weeks ago treated it as indigestion. Weight 56.2 kg, down 5 kg. Pulse 102; epigastric tenderness; slight scleral icterus; no mass or nodes. Results today: hemoglobin 9.1 g/dL, MCV 74 fL, ferritin 6 ng/mL, platelets 388; glucose 132 mg/dL and A1c 6.6%; alkaline phosphatase 236 U/L, total bilirubin 1.6 mg/dL, ALT 48 and AST 41 U/L; lipase 52 U/L; creatinine 0.70 mg/dL; albumin 3.6 g/dL. Started on pantoprazole; intravenous iron arranged. No medicines before today; no known allergies. Never smoker. Her father died suddenly of a cerebral hemorrhage; no known cancer in her family. She is a playwright finishing a new play, wants to be told everything plainly, and wants to keep writing through any treatment [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
5 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Pantoprazole 40 mg delayed-release oral tablet, one tablet by mouth once daily before breakfast | One tablet daily before breakfast | Oral route | 2026-04-20 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Epigastric pain for about two months, boring through to the back and worse after meals and lying flat, with nausea, early fullness, a loss of 5 kg (8 percent of her weight), and pale, loose stools: an upper abdominal cause such as a bleeding ulcer or a pancreatic or duodenal tumor must be found. Upper endoscopy and pancreas-protocol CT booked this week | active | confirmed | R10.13 | S — Synthetic presenting problem anchored to the documented collapse in pain and the account of a suspected duodenal ulcer. Superseded by the diagnosis at the second visit. |
| Iron deficiency anemia from chronic upper gastrointestinal blood loss: black stools on and off for three weeks, two near-fainting spells, hemoglobin 9.1 g/dL, MCV 74 fL, ferritin 6 ng/mL | active | confirmed | D50.0 | S — Synthetic finding anchored to the documented account that she was told she had anemia and bleeding ulcers. |
| New hyperglycemia: A1c 6.6% and random glucose 132 mg/dL in a lean woman of 32 who is losing weight; new diabetes with weight loss can be the first sign of a pancreatic cancer, so it is to be confirmed and explained, not labeled type 2 | active | confirmed | R73.09 | S — Synthetic finding; superseded when diabetes due to the pancreatic cancer was recorded at the second visit. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died suddenly of a cerebral hemorrhage when she was sixteen; no cancer recorded in the cited source | D (CLM-0003) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-20 | Body height | 163 | cm | S |
| 2026-04-20 | Body weight | 56.2 | kg | S |
| 2026-04-20 | Body mass index (BMI) [Ratio] | 21.2 | kg/m2 | S |
| 2026-04-20 | Systolic blood pressure | 104 | mm[Hg] | S |
| 2026-04-20 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-04-20 | Heart rate | 102 | /min | S |
| 2026-04-20 | Respiratory rate | 16 | /min | S |
| 2026-04-20 | Body temperature | 36.8 | Cel | S |
| 2026-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-20 | Hemoglobin [Mass/volume] in Blood | 9.1 | g/dL | 12-15.5 g/dL | Low | S |
| 2026-04-20 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 74 | fL | 80-100 fL | Low | S |
| 2026-04-20 | Leukocytes [#/volume] in Blood by Automated count | 7.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-04-20 | Platelets [#/volume] in Blood by Automated count | 388 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-04-20 | Ferritin [Mass/volume] in Serum or Plasma | 6 | ng/mL | 15-150 ng/mL | Low | S |
| 2026-04-20 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-20 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-04-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 118 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-20 | Glucose [Mass/volume] in Serum or Plasma | 132 | mg/dL | 70-99 mg/dL | High | S |
| 2026-04-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 48 | U/L | 7-35 U/L | High | S |
| 2026-04-20 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 8-35 U/L | High | S |
| 2026-04-20 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 236 | U/L | 35-104 U/L | High | S |
| 2026-04-20 | Bilirubin.total [Mass/volume] in Serum or Plasma | 1.6 | mg/dL | 0.1-1.2 mg/dL | High | S |
| 2026-04-20 | Albumin [Mass/volume] in Serum or Plasma | 3.6 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-04-20 | Lipase [Enzymatic activity/volume] in Serum or Plasma | 52 | U/L | 13-60 U/L | Normal | S |
| 2026-04-20 | Hemoglobin A1c/Hemoglobin.total in Blood | 6.6 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetes | High | S |
| 2026-04-20 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-04-20 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S |